相似文献
1
The COVID-19 pandemic and pulmonary arterial hypertension in Italy: adaptation, outcomes and valuable lessons learned.
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.00796-2022. Print 2022 Oct.
2
Pulmonary arterial hypertension and COVID-19: Piecing the puzzle.
Respir Med Res. 2023 Nov;84:101053. doi: 10.1016/j.resmer.2023.101053. Epub 2023 Oct 8.
3
Effects of COVID-19 pandemic on the management of pulmonary hypertension.
Respir Med. 2023 Jan;206:107061. doi: 10.1016/j.rmed.2022.107061. Epub 2022 Nov 26.
4
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.02276-2021. Print 2022 Oct.
5
Call it by the correct name-pulmonary hypertension not pulmonary arterial hypertension: growing recognition of the global health impact for a well-recognized condition and the role of the Pulmonary Vascular Research Institute.
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L992-L994. doi: 10.1152/ajplung.00098.2020. Epub 2020 Apr 1.
6
Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review.
J Heart Lung Transplant. 2021 Mar;40(3):172-182. doi: 10.1016/j.healun.2020.12.005. Epub 2020 Dec 19.
7
Patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension during the COVID-19 pandemic (2020-2022): clinical outcomes, prognostic factors, and response to vaccination.
Pol Arch Intern Med. 2024 Mar 27;134(3). doi: 10.20452/pamw.16706. Epub 2024 Mar 19.
8
Pulmonary arterial hypertension registries: past, present and into the future.
Eur Respir Rev. 2019 Dec 18;28(154). doi: 10.1183/16000617.0128-2019. Print 2019 Dec 31.
9
Surgery in phase 3 of the COVID-19 pandemic in Northern Italy spoke hospitals. Comments to "reply to letter to the editor: Surgery in the COVID-19 phase 2 Italian scenario: Lessons learned in Northern Italy spoke hospitals".
J Trauma Acute Care Surg. 2021 Feb 1;90(2):e60. doi: 10.1097/TA.0000000000003023.
10
[Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future].
Ter Arkh. 2021 Sep 15;93(9):1009-1017. doi: 10.26442/00403660.2021.09.201013.
引用本文的文献
1
Clinical use of macitentan in the treatment of connective tissue disease-associated pulmonary arterial hypertension.
J Thorac Dis. 2024 Mar 29;16(3):2060-2069. doi: 10.21037/jtd-24-151. Epub 2024 Mar 27.
2
COVID-19 vaccination for children with pulmonary hypertension: efficacy, safety and reasons for opting against vaccination.
Front Pediatr. 2023 Oct 4;11:1259753. doi: 10.3389/fped.2023.1259753. eCollection 2023.
本文引用的文献
1
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.02276-2021. Print 2022 Oct.
2
Pulmonary arterial hypertension and right ventricular systolic dysfunction in COVID-19 survivors.
Cardiol J. 2022;29(1):163-165. doi: 10.5603/CJ.a2021.0159. Epub 2021 Dec 13.
3
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective.
Nat Rev Cardiol. 2022 May;19(5):314-331. doi: 10.1038/s41569-021-00640-2. Epub 2021 Dec 6.
4
Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from the Hellenic pulmOnary hyPertension rEgistry (HOPE).
Hellenic J Cardiol. 2022 Mar-Apr;64:93-96. doi: 10.1016/j.hjc.2021.10.002. Epub 2021 Nov 26.
5
Factors Influencing the Evolution of Pulmonary Hypertension in Previously Healthy Subjects Recovering from a SARS-CoV-2 Infection.
J Clin Med. 2021 Nov 12;10(22):5272. doi: 10.3390/jcm10225272.
6
Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the Pandemic.
J Clin Med. 2021 Sep 16;10(18):4195. doi: 10.3390/jcm10184195.
7
Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis.
Sci Rep. 2021 Sep 7;11(1):17774. doi: 10.1038/s41598-021-96955-8.
8
Acute pulmonary hypertension and short-term outcomes in severe Covid-19 patients needing intensive care.
Acta Anaesthesiol Scand. 2021 Jul;65(6):761-769. doi: 10.1111/aas.13819. Epub 2021 Mar 27.
9
COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match?
Ann Am Thorac Soc. 2021 Jun;18(6):1080-1081. doi: 10.1513/AnnalsATS.202012-1498LE.
10
Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS).
Front Mol Biosci. 2021 Jan 18;7:624093. doi: 10.3389/fmolb.2020.624093. eCollection 2020.
Zotero 插件